T2 Biosystems, Inc. 8-K Report: Key Updates from January 16, 2025
Based on the provided section of the financial report, here are the key pieces of information extracted:
- Company Identification:
- Name: T2 Biosystems, Inc.
- CIK Number: 0001492674
- State of Incorporation: Delaware (DE)
- IRS Employer Identification Number (EIN): 20-4827488
- Address: 101 Hartwell Avenue, Lexington, MA 02421
- Phone Number: (781) 761-4646
- Filing Information:
- Filing Type: 8-K (Current Report)
- Filing Date: January 16, 2025
- SEC File Number: 001-36571
- Stock Information:
- Common Stock Par Value: $0.001 per share
- Stock Symbol: TTOO
- Stock Exchange: NASDAQ
- Reporting Context:
- Period Covered: The report covers a single day, January 16, 2025.
- Duration ID: duration_2025-01-16_to_2025-01-16
Insights:
- The filing is an 8-K, typically used to report significant events or corporate changes that may affect the company or its securities.
- The date of the report indicates it is likely to contain timely information regarding recent developments in the company as of January 16, 2025.
- The company's stock is publicly traded on NASDAQ, which provides a platform for investor evaluation and access to market performance data.
This information is critical for investors and stakeholders monitoring T2 Biosystems, Inc. for compliance, operational updates, or market activity.